South Korean deal fuels growth for Memphis biotech biz
Hera Health Solutions CEO Idicula Mathew (left) signs an agreement with Geovista CEO Dr. Gook Jun Ahn in Seoul, South Korea, on Oct. 17. (Courtesy Idicula Mathew)
Hera Health is experiencing a growth spurt after striking a deal that allows a South Korean company to use technology developed in Memphis in Asia’s veterinary-drug market.
Topics
Hera Health Solutions Idicula Mathew pharmaceuticals biotech EpiCenterAisling Mäki
Aisling Mäki has spent the better part of two decades writing about Memphis. A former digital journalist for WMC Action News 5 and staff reporter for Memphis Daily News, her work has also appeared in The Commercial Appeal, High Ground News, I Love Memphis, Inside Memphis Business, The Memphis Flyer, Memphis Parent, Memphis Magazine and Tri-State Defender.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.